Calamos Wealth Management LLC Johnson & Johnson Transaction History

Calamos Wealth Management LLC

$1.89 Billion
Q3 2024

A detailed history of Calamos Wealth Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Calamos Wealth Management LLC holds 42,523 shares of JNJ stock, worth $6.57 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

42,523

Previous 42,834 0.73%

Holding current value

$6.57 Million

Previous $6.26 Million 10.08%

% of portfolio

0.36%

Previous 0.34%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $45,244 - $52,055	-311 Reduced 0.73%	42,523 $6.89 Million
Q2 2024 Jul 25, 2024	BUY	$144.38 - $157.78 $1.09 Million - $1.19 Million	7,557 Added 21.42%	42,834 $6.26 Million
Q1 2024 May 08, 2024	BUY	$155.22 - $162.74 $704,077 - $738,188	4,536 Added 14.76%	35,277 $5.58 Million
Q4 2023 Jan 31, 2024	BUY	$145.6 - $158.88 $1.5 Million - $1.63 Million	10,280 Added 50.24%	30,741 $4.82 Million
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $226,304 - $253,519	1,453 Added 7.64%	20,461 $3.19 Million
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $37,661 - $40,530	-244 Reduced 1.27%	19,008 $3.15 Million
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $54,982 - $65,614	-364 Reduced 1.86%	19,252 $2.98 Million
Q4 2022 Jan 25, 2023	BUY	$160.2 - $179.79 $19,384 - $21,754	121 Added 0.62%	19,616 $0
Q3 2022 Oct 24, 2022	SELL	$161.33 - $179.52 $417,844 - $464,956	-2,590 Reduced 11.73%	19,495 $3.19 Million
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $34,478 - $38,132	-205 Reduced 0.92%	22,085 $3.92 Million
Q1 2022 May 03, 2022	BUY	$158.14 - $179.59 $246,223 - $279,621	1,557 Added 7.51%	22,290 $3.95 Million
Q4 2021 Feb 01, 2022	SELL	$155.93 - $173.01 $190,078 - $210,899	-1,219 Reduced 5.55%	20,733 $3.55 Million
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $105,782 - $117,552	-655 Reduced 2.9%	21,952 $3.55 Million
Q2 2021 Jul 22, 2021	BUY	$159.48 - $171.07 $71,447 - $76,639	448 Added 2.02%	22,607 $3.72 Million
Q1 2021 Apr 12, 2021	BUY	$153.07 - $170.48 $206,950 - $230,488	1,352 Added 6.5%	22,159 $3.64 Million
Q4 2020 Jan 27, 2021	BUY	$137.11 - $157.38 $742,313 - $852,055	5,414 Added 35.17%	20,807 $3.28 Million
Q3 2020 Oct 26, 2020	BUY	$140.38 - $153.83 $42,254 - $46,302	301 Added 1.99%	15,393 $2.29 Million
Q2 2020 Jul 27, 2020	SELL	$128.81 - $155.51 $157,921 - $190,655	-1,226 Reduced 7.51%	15,092 $2.12 Million
Q1 2020 Apr 28, 2020	SELL	$111.14 - $153.99 $1.14 Million - $1.58 Million	-10,236 Reduced 38.55%	16,318 $2.14 Million
Q4 2019 Jan 15, 2020	SELL	$127.5 - $146.44 $132,090 - $151,711	-1,036 Reduced 3.75%	26,554 $3.87 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $432,772 - $484,555	-3,409 Reduced 11.0%	27,590 $3.57 Million
Q2 2019 Aug 07, 2019	SELL	$131.15 - $144.24 $313,317 - $344,589	-2,389 Reduced 7.16%	30,999 $4.32 Million
Q1 2019 Apr 12, 2019	SELL	$125.72 - $139.79 $5.1 Million - $5.67 Million	-40,583 Reduced 54.86%	33,388 $4.67 Million
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $841,085 - $1.01 Million	-6,847 Reduced 8.47%	73,971 $9.55 Million
Q3 2018 Oct 22, 2018	SELL	$121.58 - $142.88 $514,526 - $604,668	-4,232 Reduced 4.98%	80,818 $11.2 Million
Q2 2018 Jul 17, 2018	BUY	$119.4 - $131.76 $60,297 - $66,538	505 Added 0.6%	85,050 $10.3 Million
Q1 2018 Apr 13, 2018	BUY	$125.1 - $148.14 $123,849 - $146,658	990 Added 1.18%	84,545 $10.8 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $137,387 - $150,370	1,047 Added 1.27%	83,555 $11.7 Million
Q3 2017 Oct 25, 2017	BUY	$129.47 - $135.38 $847,640 - $886,332	6,547 Added 8.62%	82,508 $10.7 Million
Q2 2017 Aug 09, 2017	BUY	N/A	75,961	75,961 $10 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Johnson & Johnson Transaction History